Is antiviral treatment used for pemphigus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antiviral Treatment in Pemphigus

Antiviral medications are not part of the standard treatment for pemphigus vulgaris itself, but are indicated when herpes simplex virus (HSV) infections occur as a complication of immunosuppressive therapy used to treat pemphigus.

Relationship Between Pemphigus and Viral Infections

Pemphigus is an autoimmune blistering disease where the primary treatment involves immunosuppression, not antiviral therapy. However, viral complications are important to recognize:

  • HSV infections are not a triggering factor for pemphigus but rather a frequent and early complication of the immunosuppressive treatment 1
  • Studies show that oral swabs were positive for HSV-1 in patients treated with oral corticosteroids, but not in untreated patients 1
  • Patients starting intensive immunosuppressive therapy can rapidly develop HSV infections, necessitating antiviral therapy 1

Standard Treatment for Pemphigus

According to the British Association of Dermatologists' guidelines, the standard treatment approach for pemphigus includes:

  1. First-line therapy:

    • Systemic corticosteroids (prednisolone) 2
    • Rituximab combined with short-term corticosteroids (most effective first-line treatment, achieving 89% complete remission at 2 years) 3, 4
  2. Adjuvant therapies:

    • Azathioprine (1-3 mg/kg/day) 2, 3
    • Mycophenolate mofetil (1g twice daily) 3
    • Intravenous immunoglobulin in severe cases 3

When Antiviral Treatment Is Indicated in Pemphigus

Antiviral therapy should be initiated in the following scenarios:

  1. Confirmed HSV infection: When HSV is detected in skin or mucosal lesions of pemphigus patients on immunosuppressive therapy 1, 5

  2. Prophylaxis: The Centers for Disease Control and Prevention recommends herpes virus prophylaxis during immunosuppressive treatment for pemphigus, particularly with rituximab 3

  3. Severe presentations: In cases of severe generalized herpes infection in pemphigus patients requiring systemic anti-viral therapy 5

Recommended Antiviral Approach

When HSV infection is suspected or confirmed in pemphigus patients:

  1. Diagnostic testing:

    • Perform viral studies (PCR) on skin/mucosal swabs to confirm HSV infection 1, 5
    • This is particularly important in patients who experience sudden exacerbations while on immunosuppressive therapy
  2. Treatment:

    • For localized HSV infections: Topical antiviral agents
    • For systemic or severe infections: Oral acyclovir, valacyclovir, or famciclovir
    • For severe cases: Intravenous acyclovir 5
  3. Prophylaxis:

    • Consider prophylactic antiviral therapy in patients receiving high-dose corticosteroids or rituximab 3
    • Particularly important for patients with a history of recurrent HSV infections

Clinical Pearls and Pitfalls

  • HSV infections can mimic or exacerbate pemphigus lesions, leading to incorrect escalation of immunosuppressive therapy instead of adding antiviral treatment
  • Failure to recognize and treat HSV infections in pemphigus patients can lead to widespread viral dissemination due to impaired immune function
  • Regular monitoring for viral infections should be part of the management protocol for pemphigus patients on immunosuppressive therapy
  • Early initiation of antiviral therapy is crucial when HSV infection is detected in immunosuppressed pemphigus patients 5

Remember that while antivirals are not used to treat pemphigus itself, they play a critical role in managing viral complications that can significantly impact morbidity and mortality in these immunocompromised patients.

References

Research

Herpes simplex virus infection and pemphigus.

International journal of immunopathology and pharmacology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pemphigus Vulgaris Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.